- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/33 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Clostridium (G)
Patent holdings for IPC class C07K 14/33
Total number of patents in this class: 799
10-year publication summary
|
49
|
43
|
52
|
57
|
61
|
58
|
54
|
44
|
45
|
23
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2337 |
57 |
| MERZ PHARMA GmbH & CO. KGaA | 609 |
35 |
| Ipsen Biopharm Limited | 264 |
34 |
| President and Fellows of Harvard College | 5995 |
26 |
| Glaxosmithkline Biologicals S.A. | 1650 |
22 |
| Children's Medical Center Corporation | 1878 |
22 |
| Ipsen Bioinnovation Limited | 40 |
19 |
| Wisconsin Alumni Research Foundation | 3888 |
18 |
| The Regents of the University of California | 20059 |
15 |
| Pfizer Inc. | 3368 |
13 |
| Wyeth LLC | 657 |
13 |
| Revance Therapeutics, Inc. | 127 |
12 |
| Daewoong Co., Ltd. | 62 |
11 |
| Valneva Austria GmbH | 115 |
11 |
| Massachusetts Institute of Technology | 10102 |
10 |
| The Governors of the University of Alberta | 873 |
7 |
| New York University | 1755 |
7 |
| Osaka University | 3383 |
7 |
| University of Guelph | 359 |
7 |
| Vaxiion Therapeutics, LLC | 20 |
7 |
| Other owners | 446 |